Ibrutix (Ibrutinib) 140 MG – 120 CAPSULES

$480.00

Ibrutix 140 mg (Ibrutinib) is used to treat:

  • Mantle Cell Lymphoma (MCL) after one prior therapy.
  • Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).
  • CLL/SLL with 17p deletion.
  • Waldenstrom’s Macroglobulinemia (WM).
  • Marginal Zone Lymphoma (MZL) after one anti-CD20-based therapy.
whatsapp_qr
Whatsapp +8801922101029